FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

332350005: Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3693200014 Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3693202018 Erythromycin 20 mg/g cutaneous gel en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3512991000005110 erythromycin 2 % gel til topikal anvendelse da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Is a erythromycin til topikal anvendelse false Inferred relationship Some
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Is a erythromycin til topikal anvendelse false Inferred relationship Some
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Erythromycin (substance) false Inferred relationship Some
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Baktericid false Inferred relationship Some
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form kutan OG/ELLER transdermal doseringsform false Inferred relationship Some
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form Cutaneous gel true Inferred relationship Some
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Erythromycin (substance) true Inferred relationship Some 1
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has concentration strength denominator value en false Inferred relationship Some 1
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 1
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has concentration strength numerator value 20 false Inferred relationship Some 1
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Erythromycin (substance) true Inferred relationship Some 1
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Count of base of active ingredient en false Inferred relationship Some
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) This attribute specifies the denominator unit for the concentration strength of a product. g true Inferred relationship Some 1
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Is a Product containing only erythromycin in cutaneous dose form (medicinal product form) true Inferred relationship Some
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Plays role Antibacterial therapeutic role (role) false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start